The US Department of Health
and Human Services has been
commissioned to convene a Federal
Interagency Steering Committee to
establish a National Action Plan to
focus on adverse drug event (ADE)
prevention, according to a release
from the Joint Commission Journal
on Quality and Patient Safety.
The decision was made to
target three medication classes:
anticoagulants, diabetes agents
(insulin and oral hypoglycemic
agents), and opioids, the report
said.
One measure of the ADE Action
Plan’s success will relate to the
wider dissemination of information
and educational resources.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 15
AUSTRALIA needs more pharmacists than ever, in the face of an ageing population and rising healthcare demands, according to the Pharmaceutical Society of Australia (PSA).
INTERN pharmacists from Monash University are set to join Victoria’s immunisation workforce under a new Secretary Approval by the Victorian Health Department.
VIRTUAL care delivered through telephone or video conference has now embedded itself as a core component of healthcare delivery in NSW, new market reports released today have revealed.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.